M&A Deal Summary |
|
|---|---|
| Date | 2025-09-23 |
| Target | Alvogen |
| Sector | Life Science |
| Buyer(s) | Lotus |
| Sellers(s) |
Athyrium Capital Management
CVC Capital Partners Temasek Holdings |
| Deal Type | Add-on Acquisition |
| Deal Value | 2.0B USD |
| Advisor(s) | Jefferies (Financial) White & Case (Legal) |
SEARCH BY
Lotus is an international pharmaceutical company with a global presence, focused on commercializing both novel and generic pharmaceuticals to provide patients with better, safer, and more accessible medicines. Lotus was founded in 1966 and is based in Taipei, Taiwan.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| Category | Asset Manager |
|---|---|
| Founded | 2008 |
| PE ASSETS | 4.6B USD |
| Size | Large |
| Type | Sector Focused |
Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 12 |
| Sector: Life Science M&A | 7 of 7 |
| Type: Add-on Acquisition M&A Deals | 4 of 5 |
| State: New Jersey M&A | 2 of 2 |
| Country: United States M&A | 10 of 11 |
| Year: 2025 M&A | 2 of 3 |
| Size (of disclosed) | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-02-04 |
Pharmaceutics International
Hunt Valley, Maryland, United States Pharmaceutics International (Pii) is a privately held contract development and manufacturing organization providing dosage form development and manufacturing services to the global pharmaceutical industry. It provides preformulation testing, formulation development, clinical and commercial CGMP manufacturing of solid, parenteral, inhalation, semi-solid and liquid dosage forms, clinical packaging and labeling, and analytical services. Pharmaceutics International was founded in 1994 and is based in Hunt Valley, Maryland. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-10-29 |
Clario
Philadelphia, Pennsylvania, United States Clario offers a compelling combination of technology, services, and clinical expertise, helping customers to deliver successful clinical trial outcomes by ensuring high-quality data capture, reduced costs, and shortened study timelines. Clario was founded in 1972 and is based in Philadelphia, Pennsylvania. |
Sell | $8.9B |
| Category | Private Equity Firm |
|---|---|
| Founded | 1981 |
| PE ASSETS | 177.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
CVC Capital Partners is a global private equity firm focused on investments in large companies located in Europe, North America, and Asia. CVC looks for opportunities with stable cash flows and talented management, and will consider businesses in a variety of industries. Target sectors include textiles, industrial products, waste management, building materials, energy/utilities, business services, financial services, distribution, healthcare, media, semiconductors, and gaming. CVC can handle transactions valued from €200 million to €10 billion. CVC Capital Partners was formed in 1981 and is based in Luxembourg.
| DEAL STATS | # |
|---|---|
| Overall | 178 of 181 |
| Sector: Life Science M&A | 5 of 5 |
| Type: Add-on Acquisition M&A Deals | 67 of 69 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 16 of 18 |
| Year: 2025 M&A | 5 of 8 |
| Size (of disclosed) | 15 of 57 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-03-25 |
Hargreaves Lansdown
Bristol, United Kingdom Hargreaves Lansdown is a helper of investors to make more of their investments by providing information, service and the best prices. They are a fund supermarket, a fund manager, a discount broker, a stockbroker, a pensions specialist, an annuity specialist, a wealth manager and a financial adviser. In other words, a one-stop shop. Hargreaves Lansdown was founded in 1981 and is based in Bristol, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-10-03 |
Bamboo
Midvale, Utah, United States Bamboo is a capital-light, tech- and data-enabled insurance distribution platform providing insurance offerings to the residential property market in California. The company operates primarily through its full-service MGA business, where it manages all aspects of the placement process on behalf of its fronting and (re)insurance partners, including product development, marketing, underwriting, policy issuance, and claims oversight, and earns commissions based on the volume and profitability of the insurance that it places. Bamboo Insurance is based in Midvale, Utah. |
Buy | $1.8B |
| Category | Sovereign Wealth Fund |
|---|---|
| Founded | 1974 |
| PE ASSETS | 434.0B SGD |
| Size | Mega |
| Type | Sector Agnostic |
Temasek Holdings is a state-owned investment holding company. Temasek is owned by the government of Singapore and invests directly and indirectly in a broad range of assets and sectors. Target sectors include financial services, telecommunications, media, technology, transportation, industrials, life science, consumer, real estate, energy, and resources. Temasek was formed in 1974 and is based in Singapore.
| DEAL STATS | # |
|---|---|
| Overall | 20 of 20 |
| Sector: Life Science M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 9 of 9 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 7 of 7 |
| Year: 2025 M&A | 2 of 2 |
| Size (of disclosed) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-03-31 |
Novotech
Sydney, Australia Novotech is a full-service contract research organization (CRO) that provides biotech and small- to mid-sized pharmaceutical companies. Novotech was founded in 1997 and is headquartered in Sydney, New South Wales. |
Buy | - |
